Skip to Main Content

Author Details

Vijay Walia
National Center for Toxicological Research
2006
21
16
PMIDPaper TitleJournal TitlePublished Year
32940377Quantification of cancer driver mutations in human breast and lung DNA using targeted, error-corrected CarcSeq.Environ Mol Mutagen2020
32940377Quantification of cancer driver mutations in human breast and lung DNA using targeted, error-corrected CarcSeq.Environ Mol Mutagen2020
31204173Akt Regulates a Rab11-Effector Switch Required for Ciliogenesis.Dev Cell2019
31467083The C7orf43/TRAPPC14 component links the TRAPPII complex to Rabin8 for preciliary vesicle tethering at the mother centriole during ciliogenesis.J Biol Chem2019
31204173Akt Regulates a Rab11-Effector Switch Required for Ciliogenesis.Dev Cell2019
31467083The C7orf43/TRAPPC14 component links the TRAPPII complex to Rabin8 for preciliary vesicle tethering at the mother centriole during ciliogenesis.J Biol Chem2019
29318547Analysis of Enzymatic Activity of Matrix Metalloproteinase (MMP) by Collagen Zymography in Melanoma.Methods Mol Biol2018
29259016Oncogenic RAS-Induced Perinuclear Signaling Complexes Requiring KSR1 Regulate Signal Transmission to Downstream Targets.Cancer Res2018
29318547Analysis of Enzymatic Activity of Matrix Metalloproteinase (MMP) by Collagen Zymography in Melanoma.Methods Mol Biol2018
29259016Oncogenic RAS-Induced Perinuclear Signaling Complexes Requiring KSR1 Regulate Signal Transmission to Downstream Targets.Cancer Res2018
26930581CLCA2 Interactor EVA1 Is Required for Mammary Epithelial Cell Differentiation.PLoS One2016
26930581CLCA2 Interactor EVA1 Is Required for Mammary Epithelial Cell Differentiation.PLoS One2016
25812525Early steps in primary cilium assembly require EHD1/EHD3-dependent ciliary vesicle formation.Nat Cell Biol2015
25686250Early steps in primary cilium assembly require EHD1/EHD3-dependent ciliary vesicle formation.Nat Cell Biol2015
25812525Early steps in primary cilium assembly require EHD1/EHD3-dependent ciliary vesicle formation.Nat Cell Biol2015
26816441Delving into the perpetual debate in psychiatry.Indian J Psychiatry2015
26816441Delving into the perpetual debate in psychiatry.Indian J Psychiatry2015
25686250Early steps in primary cilium assembly require EHD1/EHD3-dependent ciliary vesicle formation.Nat Cell Biol2015
25113440Mutational and functional analysis of the tumor-suppressor PTPRD in human melanoma.Hum Mutat2014
25113440Mutational and functional analysis of the tumor-suppressor PTPRD in human melanoma.Hum Mutat2014
24386311Loss of CLCA4 promotes epithelial-to-mesenchymal transition in breast cancer cells.PLoS One2013
24386311Loss of CLCA4 promotes epithelial-to-mesenchymal transition in breast cancer cells.PLoS One2013
21909135Loss of breast epithelial marker hCLCA2 promotes epithelial-to-mesenchymal transition and indicates higher risk of metastasis.Oncogene2012
22260482Delving into somatic variation in sporadic melanoma.Pigment Cell Melanoma Res2012
21909135Loss of breast epithelial marker hCLCA2 promotes epithelial-to-mesenchymal transition and indicates higher risk of metastasis.Oncogene2012
22260482Delving into somatic variation in sporadic melanoma.Pigment Cell Melanoma Res2012
21196200Micromanagement of the mitochondrial apoptotic pathway by p53.Front Biosci (Landmark Ed)2011
21196200Micromanagement of the mitochondrial apoptotic pathway by p53.Front Biosci (Landmark Ed)2011
21499247Exome sequencing identifies GRIN2A as frequently mutated in melanoma.Nat Genet2011
21946352Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma.Nat Genet2011
21946352Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma.Nat Genet2011
21499247Exome sequencing identifies GRIN2A as frequently mutated in melanoma.Nat Genet2011
20222827Enrichment for breast cancer cells with stem/progenitor properties by differential adhesion.Stem Cells Dev2010
20222827Enrichment for breast cancer cells with stem/progenitor properties by differential adhesion.Stem Cells Dev2010
19202062p53 represses c-Myc through induction of the tumor suppressor miR-145.Proc Natl Acad Sci U S A2009
19202062p53 represses c-Myc through induction of the tumor suppressor miR-145.Proc Natl Acad Sci U S A2009
19654313hCLCA2 Is a p53-Inducible Inhibitor of Breast Cancer Cell Proliferation.Cancer Res2009
19654313hCLCA2 Is a p53-Inducible Inhibitor of Breast Cancer Cell Proliferation.Cancer Res2009
17485365p53 in breast cancer: mutation and countermeasures.Front Biosci2007
17485365p53 in breast cancer: mutation and countermeasures.Front Biosci2007
16873362The putative chloride channel hCLCA2 has a single C-terminal transmembrane segment.J Biol Chem2006
16873362The putative chloride channel hCLCA2 has a single C-terminal transmembrane segment.J Biol Chem2006
  • 1 - 42 of 42

Recommended Authors

Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 1
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 0
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 0
Amsterdam University Medical Centers location AMC
Career Start Year 1999
Number of shared co-authors 0
Western University
Career Start Year 1999
Number of shared co-authors 0
Uppsala University
Career Start Year 1999
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 0
University of South Carolina
Career Start Year 1993
Number of shared co-authors 7
Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Career Start Year 1992
Number of shared co-authors 9
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 3
Uppsala University
Career Start Year 1991
Number of shared co-authors 0
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 0
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 3
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 2
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 1
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Dana-Farber Cancer Institute
Career Start Year 1984
Number of shared co-authors 2
Peter MacCallum Cancer Centre
Career Start Year 1983
Number of shared co-authors 1
UCSF Helen Diller Family Comprehensive Cancer Center
Career Start Year 1982
Number of shared co-authors 0
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 1
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1981
Number of shared co-authors 7
Wellcome Sanger Institute
Career Start Year 1980
Number of shared co-authors 2
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 0
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 3

Collaborators

Weizmann Institute of Science
Co-authored papers 5
Center for Cancer Research
Co-authored papers 5
National Human Genome Research Institute, US National Institutes of Health
Co-authored papers 4
Brody School of Medicine, East Carolina University
Co-authored papers 4
University of Colorado School of Medicine
Co-authored papers 3
National Cancer Institute
Co-authored papers 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Cornell University
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
MD Anderson Cancer Center, University of Texas
Co-authored papers 2
Center for Cancer Research, National Cancer Institute-Frederick
Co-authored papers 2
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 2
Stanford University School of Medicine, Center for Clinical Sciences Research
Co-authored papers 2
University of Colorado Anschutz Medical Campus
Co-authored papers 1
National Centre for Asbestos Related Diseases, University of Western Australia
Co-authored papers 1
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 1
University of Sheffield
Co-authored papers 1
Co-authored papers 1
University of California
Co-authored papers 1
Co-authored papers 1
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Sanford School of Medicine, University of South Dakota
Co-authored papers 1